NEU1 and Alzheimer disease: Therefore, achieving precise control over NEU1 activity through methodologies that focus on cell type-specific delivery, temporal regulation and comprehensive safety profiling is important for the successful clinical translation of NEU1-targeted interventions in diseases like AD [58].